MENU
+Compare
GLUE
Stock ticker: NASDAQ
AS OF
Sep 15, 04:59 PM (EDT)
Price
$6.92
Change
+$2.10 (+43.66%)
Capitalization
427.99M

GLUE Monte Rosa Therapeutics Forecast, Technical & Fundamental Analysis

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins... Show more

GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GLUE with price predictions
Sep 12, 2025

GLUE's RSI Indicator ascends from oversold territory

The RSI Indicator for GLUE moved out of oversold territory on August 08, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 23 similar instances when the indicator left oversold territory. In of the 23 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for GLUE just turned positive on August 22, 2025. Looking at past instances where GLUE's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GLUE advanced for three days, in of 244 cases, the price rose further within the following month. The odds of a continued upward trend are .

GLUE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 113 cases where GLUE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 37 cases where GLUE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on September 12, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on GLUE as a result. In of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

GLUE moved below its 50-day moving average on September 04, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for GLUE crossed bearishly below the 50-day moving average on August 08, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.108) is normal, around the industry mean (20.731). P/E Ratio (12.333) is within average values for comparable stocks, (53.474). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.171). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (2.230) is also within normal values, averaging (337.655).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GLUE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GLUE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

GLUE is expected to report earnings to fall 8.34% to -32 cents per share on November 06

Monte Rosa Therapeutics GLUE Stock Earnings Reports
Q3'25
Est.
$-0.33
Q2'25
Beat
by $0.02
Q1'25
Beat
by $1.01
Q4'24
Missed
by $0.54
Q3'24
Beat
by $0.18
The last earnings report on August 07 showed earnings per share of -35 cents, beating the estimate of -37 cents. With 31.45M shares outstanding, the current market capitalization sits at 427.99M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 949-2643
Employees
133
Web
https://www.monterosatx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPXSY47.200.06
+0.14%
SPIRAX GROUP PLC
DIGTF0.02N/A
N/A
Thruvision Group PLC
MCRAB45.00N/A
N/A
McRae Industries, Inc.
MIZUF17.35N/A
N/A
Mizuno Corp.
PBCRF0.45N/A
N/A
PT Bank Central Asia

GLUE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with EYPT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
-1.64%
EYPT - GLUE
48%
Loosely correlated
+0.15%
NRIX - GLUE
40%
Loosely correlated
-1.74%
IMNM - GLUE
40%
Loosely correlated
-4.86%
FATE - GLUE
39%
Loosely correlated
-5.58%
ATXS - GLUE
39%
Loosely correlated
-5.23%
More